A broader perspective on personalized medicine: Lessons from discourse analysis and knowledge translation

Current Pharmacogenomics and Personalized Medicine

Volumn 10, Issue 3, 2012, Pages 179-181

  Holmes, Bev J ^a,b,c  

^a Canadian Institutes of Health Research   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Communication studies; Discourse analysis; Genomics and business strategy; Genomics and society; Knowledge translation; Personalized medicine; Public health pharmacogenomics; Social study of science and technology

Indexed keywords

EDITORIAL; HEALTH CARE PRACTICE; KNOWLEDGE TRANSLATION; MEDICAL RESEARCH; NANOTECHNOLOGY; PERSONALIZED MEDICINE; PROTEOMICS; TRANSLATIONAL RESEARCH;

EID: 84867024265     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569212802510003     Document Type: Editorial

References (18)

1. Straus S, Tetroe J, Graham I. Defining knowledge translation. CMAJ 2009; 181(3-4): 165-8.
2. Greenhalgh T, Wieringa S. Is it time to drop the 'knowledge translation' metaphor? A critical literature review. J R Soc Med 2011; 104: 501-9.
3. Kato K, Kano K, Shirai T. Science communication: significance for genome-based personalized medicine - a view from the Asia- Pacific. Curr Pharmacogenomics Person Med 2010; 8: 92-6.
4. Harvey A. Opinion leaders' views on issues in personalized medicine. Personalized Medicine 2012; 9(2): 127-31.
5. Lehoux P. Moving beyond our mutual ignorance. Or, how would engaging the public benefit the personalized medicine community? Curr Pharmacogenomics Person Med 2011; 9: 76-9.
6. Ozdemir V, Fisher E, Dove ES, et al. End of the beginning and public health pharmacogenomics: knowledge in 'mode 2' and P5 medicine. Curr Pharmacogenomics Person Med 2012; 10: 1-6.
7. Holmes BJ. Constructing the coming plague: a discourse analysis of the British Columbia Pandemic Influenza Preparedness Plan. Simon Fraser University PhD dissertation; 2010.
8. Gwyn R. Communicating health and illness. London: Sage Publications 2002.
9. Cheek J. At the margins? Discourse analysis and qualitative reserach. Qual Health Research 2004; 14: 1140-50.
10. Hedgecoe A. Terminology and the construction of scientific disciplines: the case of pharmacogenomics. Science Technol Human Values 2003; 28: 513-36.
11. Canadian ovarian cancer breakthrough could crack other cancers, Alaska Highway News (Fort St. John, BC) 6, 2009: A8.
12. No authors listed. From diagnosis to treatment plan in a day. National Post (Don Mills, Ont) 12, 2012: FP. 22.
13. Holmes B, Scarrow G, Schellenberg M. Translating evidence into practice: the role of health research funders. Implementation Science 2012; 7: 39.
14. Best A, Holmes BJ. Systems thinking, knowledge and action: towards better models and methods. Evidence and Policy 2010; 6(2): 135-59.
15. Holmes BJ, Finegood Dt, Riley Bl, et al. Systems theory and approaches to dissemination and implementation. In Dissemination and Implementation Research in Health: Translating Science to Practice. Editors: RC Brownson, GA Colditz, EK Proctor; 175-191. New York: Oxford University Press, 2012.
16. Huzair F, Borda-Rodriguez A, Upton M. Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs). OMICS 2011; 15(9): 539-43.
17. Nettleton S, Bunton R. Sociological critiques of health promotion. In: The Sociology of Health Promotion: Critical Analysis of Construction, Lifestyle and Risk. Eds: R Bunton, S Nettleton, R Burrows. London: Routledge; 1995, pp. 39-56.
18. Russell J, Greenhalgh T, Byrne E, et al. Recognizing rhetoric in health care policy analysis Health Serv Res Policy 2008; 13(1): 40-6.